← Back to Clinical Trials
Recruiting NCT04008329
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
Trial Parameters
Condition Amyotrophic Lateral Sclerosis
Sponsor First Affiliated Hospital of Fujian Medical University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-07-05
Completion 2029-07
Brief Summary
Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.
Eligibility Criteria
Inclusion Criteria: * Amyotrophic Lateral Sclerosis patients fulfilling the El Escorial criteria (including definite, probable and possible) * Progressive muscular atrophy * Primary lateral sclerosis * Progressive bulbar palsy Exclusion Criteria: * History of serious head trauma or neuropsychiatric disease * Decline to participate
Related Trials
NCT05204017
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
View Trial →
NCT04008329
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
View Trial →
NCT06094205
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
View Trial →